Veru Inc. (VERU): Free Cash Flow
-$30.04M
Year ended 2025-09-30
-$26.04M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$30.04M | n/m | 2025-12-17, From 2024-10-01 |
| 2024-09-30 | -$21.84M | n/m | 2025-12-17, From 2023-10-01 |
| 2023-09-30 | -$88.68M | n/m | 2024-12-16, From 2022-10-01 |
| 2022-09-30 | -$48.24M | n/m | 2024-04-01, From 2021-10-01 |
| 2021-09-30 | -$15.95M | n/m | 2022-12-05, From 2020-10-01 |
| 2020-09-30 | -$2.04M | n/m | 2021-12-02, From 2019-10-01 |
| 2019-09-30 | -$5.59M | n/m | 2020-12-10, From 2018-10-01 |
| 2018-09-30 | -$11.60M | n/m | 2019-12-12, From 2017-10-01 |
| 2017-09-30 | $849.4K | n/m | 2018-12-13, From 2016-10-01 |
| 2016-09-30 | -$1.72M | n/m | 2018-01-02, From 2015-10-01 |
| 2015-09-30 | -$1.68M | n/m | 2018-01-02, From 2014-10-01 |
| 2014-09-30 | $3.57M | -68.9% | 2016-12-12, From 2013-10-01 |
| 2013-09-30 | $11.49M | +19.2% | 2015-12-02, From 2012-10-01 |
| 2012-09-30 | $9.64M | +39.2% | 2014-12-02, From 2011-10-01 |
| 2011-09-30 | $6.92M | +75.6% | 2013-12-03, From 2010-10-01 |
| 2010-09-30 | $3.94M | -4.0% | 2012-12-04, From 2009-10-01 |
| 2009-09-30 | $4.10M | n/a | 2011-12-02, From 2008-10-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Veru Inc. (VERU) | 2025-09-30 | -$30.04M | n/m |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $275.0K | n/m |
| Talphera, Inc. (TLPH) | 2024-12-31 | -$12.68M | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.51M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$33.12M | n/m |
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | -$27.75M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $88.9K | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$13.36M | n/m |
| Skye Bioscience, Inc. (SKYE) | 2025-12-31 | -$43.07M | n/m |
Compare VERU, SLGL, TLPH, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗